164 related articles for article (PubMed ID: 19856130)
1. Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype.
Vali S; Pallavi R; Kapoor S; Tatu U
Syst Synth Biol; 2010 Mar; 4(1):25-33. PubMed ID: 19856130
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the weak ATPase activity of human hsp90 by a client protein.
McLaughlin SH; Smith HW; Jackson SE
J Mol Biol; 2002 Jan; 315(4):787-98. PubMed ID: 11812147
[TBL] [Abstract][Full Text] [Related]
3. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle.
Siligardi G; Hu B; Panaretou B; Piper PW; Pearl LH; Prodromou C
J Biol Chem; 2004 Dec; 279(50):51989-98. PubMed ID: 15466438
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Asymmetry in Hsp90 Dimers.
Flynn JM; Mishra P; Bolon DN
J Mol Biol; 2015 Sep; 427(18):2904-11. PubMed ID: 25843003
[TBL] [Abstract][Full Text] [Related]
5. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.
McLaughlin SH; Sobott F; Yao ZP; Zhang W; Nielsen PR; Grossmann JG; Laue ED; Robinson CV; Jackson SE
J Mol Biol; 2006 Feb; 356(3):746-58. PubMed ID: 16403413
[TBL] [Abstract][Full Text] [Related]
6. Hsp90: Friends, clients and natural foes.
Verma S; Goyal S; Jamal S; Singh A; Grover A
Biochimie; 2016 Aug; 127():227-40. PubMed ID: 27295069
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.
Prodromou C; Siligardi G; O'Brien R; Woolfson DN; Regan L; Panaretou B; Ladbury JE; Piper PW; Pearl LH
EMBO J; 1999 Feb; 18(3):754-62. PubMed ID: 9927435
[TBL] [Abstract][Full Text] [Related]
8. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Holmes JL; Sharp SY; Hobbs S; Workman P
Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic inhibition of the Hsp90 ATPase activity.
Richter K; Moser S; Hagn F; Friedrich R; Hainzl O; Heller M; Schlee S; Kessler H; Reinstein J; Buchner J
J Biol Chem; 2006 Apr; 281(16):11301-11. PubMed ID: 16461354
[TBL] [Abstract][Full Text] [Related]
10. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
Powers MV; Workman P
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S125-35. PubMed ID: 17259553
[TBL] [Abstract][Full Text] [Related]
11. Thr90 phosphorylation of Hsp90α by protein kinase A regulates its chaperone machinery.
Wang X; Lu XA; Song X; Zhuo W; Jia L; Jiang Y; Luo Y
Biochem J; 2012 Jan; 441(1):387-97. PubMed ID: 21919888
[TBL] [Abstract][Full Text] [Related]
12. The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition.
Serwetnyk MA; Blagg BSJ
Acta Pharm Sin B; 2021 Jun; 11(6):1446-1468. PubMed ID: 34221862
[TBL] [Abstract][Full Text] [Related]
13. A motif in HSP90 and P23 that links molecular chaperones to efficient estrogen receptor α methylation by the lysine methyltransferase SMYD2.
Obermann WMJ
J Biol Chem; 2018 Oct; 293(42):16479-16487. PubMed ID: 30190324
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23.
Young JC; Hartl FU
EMBO J; 2000 Nov; 19(21):5930-40. PubMed ID: 11060043
[TBL] [Abstract][Full Text] [Related]
15. Cns1 is an activator of the Ssa1 ATPase activity.
Hainzl O; Wegele H; Richter K; Buchner J
J Biol Chem; 2004 May; 279(22):23267-73. PubMed ID: 15044454
[TBL] [Abstract][Full Text] [Related]
16. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
Czemeres J; Buse K; Verkhivker GM
PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37.
Siligardi G; Panaretou B; Meyer P; Singh S; Woolfson DN; Piper PW; Pearl LH; Prodromou C
J Biol Chem; 2002 Jun; 277(23):20151-9. PubMed ID: 11916974
[TBL] [Abstract][Full Text] [Related]
18. Sti1 is a non-competitive inhibitor of the Hsp90 ATPase. Binding prevents the N-terminal dimerization reaction during the atpase cycle.
Richter K; Muschler P; Hainzl O; Reinstein J; Buchner J
J Biol Chem; 2003 Mar; 278(12):10328-33. PubMed ID: 12525481
[TBL] [Abstract][Full Text] [Related]
19. The Hsp90 chaperone machinery: from structure to drug development.
Hahn JS
BMB Rep; 2009 Oct; 42(10):623-30. PubMed ID: 19874705
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the ATPase activity of Hsp90 by zerumbone modification of its cysteine residues destabilizes its clients and causes cytotoxicity.
Nakamoto H; Amaya Y; Komatsu T; Suzuki T; Dohmae N; Nakamura Y; Jantan I; Miyata Y
Biochem J; 2018 Aug; 475(15):2559-2576. PubMed ID: 30045873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
